Innoviva Inc (NASDAQ:INVA)

16.14
Delayed Data
As of Apr 20
 -0.09 / -0.55%
Today’s Change
11.02
Today|||52-Week Range
17.99
+13.74%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close16.23
Today’s open16.23
Day’s range16.09 - 16.39
Volume520,335
Average volume (3 months)967,571
Market cap$1.7B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+120.75%
Earnings growth (this year)+71.19%
Earnings growth (next 5 years)+23.03%
Revenue growth (last year)+56.75%
P/E ratio13.8
Price/Sales7.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.55+1.55%
EBSEmergent BioSolution...-0.12-0.22%
MYOKMyoKardia Inc+0.80+1.64%
LXRXLexicon Pharmaceutic...+0.05+0.60%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$0.53
Annual revenue (last year)$231.0M
Annual profit (last year)$134.1M
Net profit margin58.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO, Chief Financial Officer &
Senior VP
Eric d'Esparbes
Chief Scientific Officer &
Senior Vice President
Theodore J. Witek
Corporate headquarters
Brisbane, California

Forecasts